Characteristics Associated with the Dual Behavior of Mask Wearing and Vaccine Acceptance: A Pooled Cross-Sectional Study among Adults in Saskatchewan.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
09 03 2022
Historique:
received: 03 02 2022
revised: 03 03 2022
accepted: 07 03 2022
entrez: 25 3 2022
pubmed: 26 3 2022
medline: 1 4 2022
Statut: epublish

Résumé

While the dual behavior of consistent mask wearing and vaccine acceptance represents an effective method of protecting oneself and others from COVID-19, research has yet to directly examine its predictors. A total of 3347 responses from a pooled cross-sectional survey of adults living in Saskatchewan, Canada, were analyzed using a multinomial logistic regression model. The outcome variable was the combined behavior of mask-wearing and vaccine intention in four combinations, while covariates consisted of socio-demographic factors, risk of exposure to coronavirus, mitigating behaviors, and perceptions of COVID-19. Those who were 65 years and older, financially secure, consistently practiced social distancing and had no or very few contacts with people outside their households, were concerned about spreading the virus, and perceived they would be seriously sick if infected were likely to engage in both mask wearing and vaccine acceptance, rather than one or the other, with adjusted odds ratios ranging from 2.24 to 27.54. Further, within mask wearers, these factors were associated in a graded manner with vaccine intent. By describing the characteristics of those who engage in both mask wearing and vaccine acceptance, these results offer a specific set of characteristics for public health authorities to target and, therefore, contribute to the rapidly evolving body of knowledge on protective factors for COVID-19.

Identifiants

pubmed: 35328890
pii: ijerph19063202
doi: 10.3390/ijerph19063202
pmc: PMC8953851
pii:
doi:

Substances chimiques

Influenza Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Social Contours and COVID-19 received funding from 2020 Rapid Response COVID-19 Research Award, College of Medicine, University of Saskatchewan (Fund ID: 423181). The funder had no role in study design, data collection and analysis, decision to publish, o
ID : #423181

Références

Hum Vaccin Immunother. 2021 Jun 3;17(6):1612-1621
pubmed: 33242386
JAMA. 2020 Jun 23;323(24):2458-2459
pubmed: 32421155
Public Opin Q. 2000 Summer;64(2):171-88
pubmed: 10984332
Soc Sci Med. 2021 Feb;270:113684
pubmed: 33485008
PLoS One. 2021 Mar 24;16(3):e0248892
pubmed: 33760836
J Community Health. 2021 Oct;46(5):1013-1019
pubmed: 33835369
Front Psychol. 2020 Oct 19;11:575950
pubmed: 33192883
Vaccines (Basel). 2021 Feb 16;9(2):
pubmed: 33669441
Math Biosci. 2020 Jul;325:108364
pubmed: 32360770
JAMA. 2020 Dec 29;:
pubmed: 33372943
J Racial Ethn Health Disparities. 2022 Feb;9(1):176-183
pubmed: 33469866
PLoS One. 2020 Oct 15;15(10):e0240785
pubmed: 33057375
Public Health. 2021 May;194:245-251
pubmed: 33965796
Am J Epidemiol. 2022 Jan 05;:
pubmed: 34999751
Prev Med. 2021 Sep;150:106694
pubmed: 34171345
Vaccine. 2021 Jul 30;39(33):4716-4722
pubmed: 34119349
Vaccine. 2021 Feb 12;39(7):1080-1086
pubmed: 33461833
Pers Individ Dif. 2021 Apr;172:110590
pubmed: 33518869
PLoS One. 2021 Apr 27;16(4):e0250495
pubmed: 33905442
Vaccine. 2021 May 6;39(19):2698-2711
pubmed: 33781601
PLoS One. 2021 Nov 12;16(11):e0259513
pubmed: 34767603
BMC Public Health. 2021 Apr 21;21(1):765
pubmed: 33882896
Health Place. 2021 Mar;68:102537
pubmed: 33636596
Front Psychol. 2020 Sep 30;11:551004
pubmed: 33117223
CMAJ. 2021 Mar 15;193(11):E381-E383
pubmed: 33627413
Nat Commun. 2021 Jan 4;12(1):29
pubmed: 33397962
Curr Psychol. 2021 Jan 6;:1-9
pubmed: 33424206

Auteurs

Ali Bukhari (A)

Saskatchewan Population Health and Evaluation Research Unit (SPHERU), University of Saskatchewan, 104 Clinic Place, Saskatoon, SK S7N 2Z4, Canada.

Daniel A Adeyinka (DA)

Saskatchewan Population Health and Evaluation Research Unit (SPHERU), University of Saskatchewan, 104 Clinic Place, Saskatoon, SK S7N 2Z4, Canada.
Department of Community Health and Epidemiology, College of Medicine, University of Saskatchewan, 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.

Jessica McCutcheon (J)

Canadian Hub for Applied and Social Research (CHASR), University of Saskatchewan, 9 Campus Drive, Saskatoon, SK S7N 5A5, Canada.

Natalie Kallio (N)

Saskatchewan Population Health and Evaluation Research Unit (SPHERU), University of Saskatchewan, 104 Clinic Place, Saskatoon, SK S7N 2Z4, Canada.

Nazeem Muhajarine (N)

Saskatchewan Population Health and Evaluation Research Unit (SPHERU), University of Saskatchewan, 104 Clinic Place, Saskatoon, SK S7N 2Z4, Canada.
Department of Community Health and Epidemiology, College of Medicine, University of Saskatchewan, 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH